
DCTH
Delcath Stock Jumps 36% After Quarterly Revenue Growth and Raised 2026 Guidance
The company reported third-quarter revenue of $35.1 million and increased its full-year revenue outlook to $115 million to $117 million.
Delcath Systems, Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus

The company reported third-quarter revenue of $35.1 million and increased its full-year revenue outlook to $115 million to $117 million.
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedDelcath Systems Q3 2026 Revenue of $35.1 Million Beats $25.8 Million Consensus; Diluted EPS $0.17 vs Consensus Loss of $0.08; Raises 2026 Revenue Guidance to $115-$117 Million
Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits